http://www.aquestive.com
Aquestive Therapeutics, Inc. Company Intro
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems
Industry
Healthcare
Aquestive Therapeutics, Inc. Headquaters
30 Technology Drive
Warren,07059
United States
Aquestive Therapeutics, Inc. Share price
19 Oct 2020 01:07 GMT
$4.95
-0.05 (-1.0 %)
Aquestive Therapeutics, Inc. Market cap
$169.108 M
WMC RANKING
2020
Aquestive Therapeutics, Inc. # 78
BiotechnologyLatest Aquestive Therapeutics, Inc. News
19 Oct 2020
4Cable TV International, Inc. Announces that it is Exploring the ...
The Company is considering two different CBD companies and expects to make its final ... Aquestive Therapeutics, Inc. (NASDAQ:AQST): Is Breakeven Near?
19 Oct 2020
4Cable TV International, Inc. Announces that it is Exploring the ...
The Company is considering two different CBD companies and expects to make its final ... Aquestive Therapeutics, Inc. (NASDAQ:AQST): Is Breakeven Near?
19 Oct 2020
Aquestive Therapeutics, Inc. (NASDAQ:AQST): Is Breakeven ...
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Aquestive Therapeutics, Inc. | 1.07 | 0.04 | 0 | 0 | 0 | 0 | 0.03 |
| Alexion Pharmaceuticals, Inc. | 100 | 11.32 | 100 | 20 | 0 | 0 | 96.20 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 3.68 | 33 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 0 | 0 | 0 | 0.06 |
| Incyte Corporation | 40.27 | 8.70 | 7.11 | 100 | 0 | 0 | 84.84 |
Aquestive Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Aquestive Therapeutics, Inc. | $59,277 | $75,016 | $-49,912 | $169.108M | 78 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $27.206B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $56.803B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥20.207B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.821B | 4 |